Tpn Electrolytes Injection, Solution, Concentrate
NDC Package 0409-5779-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Tpn Electrolytes (sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous) injection is tPN Electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients. This formulation utilizes a injection, solution, concentrate delivery system. Marketed by Hospira, Inc., this product is identified by NDC 0409-5779 and is authorized under FDA application NDA018895.

Identification & Billing

NDC Package Code
0409-5779-01
Package Description
25 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE (0409-5779-11)
Product Code
0409-5779
11-Digit Billing Format
00409577901
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 801451 - acetate 29.5 MEQ / calcium 4.5 MEQ / chloride 35 MEQ / magnesium 5 MEQ / potassium 20 MEQ / sodium 35 MEQ in 20 ML Injectable Solution
  • RxCUI: 801451 - calcium chloride 0.23 MEQ/ML / magnesium chloride 0.53 MEQ/ML / potassium chloride 0.1 MEQ/ML / sodium acetate 1.48 MEQ/ML / sodium chloride 0.27 MEQ/ML Injectable Solution
  • RxCUI: 801451 - Calcium Chloride 0.23 MEQ/ML / Magnesium Chloride 0.53 MEQ/ML / K+ Chloride 0.1 MEQ/ML / Sodium Acetate 1.48 MEQ/ML / NaCl 0.27 MEQ/ML Injectable Solution
  • RxCUI: 801451 - Calcium Chloride 0.23 MEQ/ML / Magnesium Chloride 0.53 MEQ/ML / Pot Chloride 0.1 MEQ/ML / Sodium Acetate 1.48 MEQ/ML / NaCl 0.27 MEQ/ML Injectable Solution

Clinical Specifications

Proprietary Name
Tpn Electrolytes
Non-Proprietary Name
Sodium Chloride, Calcium Chloride, Potassium Chloride, Magnesium Chloride, And Sodium Acetate Anhydrous
Substance Name
Calcium Chloride; Magnesium Chloride; Potassium Chloride; Sodium Acetate Anhydrous; Sodium Chloride
Dosage Form
Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
TPN Electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients.

Regulatory & Marketing

Labeler Name
Hospira, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA018895
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-28-2005
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0409-5779-01 identifies a specific commercial package of 25 vial, single-dose in 1 carton / 20 ml in 1 vial, single-dose (0409-5779-11) of Tpn Electrolytes, a human prescription drug labeled by Hospira, Inc.. This injection, solution, concentrate is formulated for intravenous use and contains calcium chloride; magnesium chloride; potassium chloride; sodium acetate anhydrous; sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hospira, Inc. on February 28, 2005. The current certification is valid through December 31, 2027.

How is this Hospira, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00409577901. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0409-5779-01
11-Digit CMS (5-4-2)
00409-5779-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.